Avid Bioservices Inc (CDMO)

[Thurly]

UCLA publishes real-time survival data for GBM.
http://www.neurooncology.ucla.edu/Performance/GlioblastomaMultiforme.aspx

What is the Average Survival of a Newly Diagnosed Glioblastoma Multiforme Patient treated by UCLA Neuro-Oncology?
There are several key factors that influence overall survival of a Glioblastoma Multiforme patient, these include initial diagnosis, number of times the tumor has recurred, patient age, molecular diagnostic results, past therapy, Karnofsky Score, tissue features, along with 50-60 other key variables. It is the job of the Neuro-Oncologist to take into account all factors and formulate the best option for you and your family.

Although it can be difficult to predict survival using just a single variable of pathology diagnosis, in general the following represents the average overall survival of Initially Diagnosed GBM patients treated by UCLA Neuro-Oncology. The patients represented all have started treatment before 2/11/2007.

Histogram Analysis & Interquartile Mean (IQM)
In statistics, a histogram is a graphical version of a table which shows what proportion of cases fall into each of several or many specified categories. The categories are usually specified as non-overlapping intervals of some variable. In this case each bar represents Overall Survival in Days.

In calculation of the Median Survival, ONLY the inter-quartile range is used, and the lowest 25% and the highest 25% of the scores are discarded.









How much experience does UCLA Neuro-Oncology have treating patients with a Glioblastoma Multiforme tumor?
A patient's tumor can often change from a lower grade tumor to a high grade tumor within a period of 24 months. In general the number of patients we treat with a diagnosis of Glioblastoma Multiforme at the time of therapy, based on data covering 2/11/2008 to 2/11/2010 are as follows:



What is the demographic breakdown of Glioblastoma Multiforme patients treated by UCLA Neuro-Oncology?
In general the number of patients we have treated with a diagnosis of Glioblastoma Multiforme at the time of treatment, based on data covering 2/11/2008 to 2/11/2010 are as follows:



Does anybody know the ages of our patients?